Novo Nordisks diabetes pill slashes risk of cardiovascular complications by 14 after four years CNBC

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes a… [+4334 chars]Read More